Hexavest’s Hologic HOLX Stock Holding History

Hexavest’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-214	Closed	-$8K	–	429
2020 Q1	$8K	Hold	214	–	–	﹤0.01%	405
2019 Q4	$11K	Hold	214	–	–	﹤0.01%	407
2019 Q3	$11K	Hold	214	–	–	﹤0.01%	452
2019 Q2	$10K	Buy	+214	New	+$9.89K	﹤0.01%	481

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hexavest's HOLX Position: Q2 2020 in Review

Hexavest sold out of Hologic (HOLX) in Q2 2020, closing a stake of 214 shares — an estimated $8K sold.

Hexavest first reported a position in HOLX in Q2 2019 and held it in 4 quarters. The position peaked at $11K in Q4 2019. 521 funds tracked by Wall St. Rank hold HOLX as of Q2 2020.

Hexavest reported no remaining Hologic position as of Q2 2020 after selling out during the quarter.
Hexavest sold 214 Hologic shares in Q2 2020, an estimated $8K.
Hexavest first reported a position in Hologic in Q2 2019 and held it in 4 quarters.
Hexavest's Hologic position peaked at $11K in Q4 2019.
521 funds tracked by Wall St. Rank held Hologic as of Q2 2020.

Based on Hexavest's 13F filing for Q2 2020, filed 10 Jul 2020.